Risk and Short-Term Prognosis of Myocardial Infarction Among Users of Antidiabetic Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk and Short-Term Prognosis of Myocardial Infarction Among Users of Antidiabetic Drugs

Published:2006-03 Issue:2 Volume:13 Page:134-140
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:American Journal of Therapeutics

Author:

Johnsen S.P.,Monster T.B.M.,Olsen M.L.,Thisted H.,McLaughlin J.K.,S??rensen H.T.,Lervang H.H.,Rungby J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference25 articles.

1. Failure to precondition pathological human myocardium

2. The Sulfonylurea Controversy: More Questions From the Heart 11This study was supported by a Clinician-Investigator Fellowship from General Mills, Rochester, Minnesota; by the American Heart Association, Minnesota Affiliate, Minneapolis; by the Miami Heart Research Institute, Miami, Florida; and by the Bruce and Ruth Rappaport Program in Vascular Biology and Gene Delivery, Geneva, Switzerland.

3. Does Ischemic Preconditioning in the Human Involve Protein Kinase C and the ATP-Dependent K + Channel?

4. Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease

5. Oral Sulfonylurea Hypoglycemic Agents Prevent Ischemic Preconditioning in Human Myocardium

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Modern Anti-Diabetic Treatment on Endothelial Progenitor Cells;Biomedicines;2023-11-14

2. Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi‐heart study;Diabetes, Obesity and Metabolism;2023-05-03

3. Therapeutic Management of Type 2 Diabetes: The Nitric Oxide Axis;The Role of Nitric Oxide in Type 2 Diabetes;2022-11-29

4. Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials;Nutrition, Metabolism and Cardiovascular Diseases;2020-09

5. Diabetes in Older People;Canadian Journal of Diabetes;2018-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3